Patents/Inventors

Thomas M. Lancaster

Wenham, MAUS12 patents

12 Patents

US126066052026
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
AKSTON BIOSCIENCES CORPORATION
0 cites
US124545652025
PD-L1 Analog Fusion Proteins for Antigen Specific Immunotherapy and Methods of Use
AKSTON BIOSCIENCES CORPORATION
0 cites
US123433932025
Antigen Specific Immunotherapy for COVID-19 Fusion Proteins and Methods of Use
Vakston, Inc.
0 cites
US122408812025
Ultra-long Acting Insulin-fc Fusion Protein and Methods of Use
Dechra Limited
0 cites
US121955112025
Ultra-long Acting Insulin-fc Fusion Protein
Akston Biosciences Corporation
0 cites
US119199352024
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites
US118144182023
Ultra-long Acting Insulin-fc Fusion Protein and Methods of Use
Akston Biosciences Corporation
0 cites
US117731512023
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites
US117075172023
Antigen Specific Immunotherapy for COVID-19 Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites
US116739342023
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
Akston Biosciences Corporation
0 cites
US116676892023
Insulin-fc Fusion Proteins and Methods of Use to Treat Cancer
Akston Biosciences Corporation
0 cites
US115550582023
Cells Engineered to Express Ultra-long Acting Insulin-fc Fusion Proteins
Akston Biosciences Corporation
0 cites